News

A multinational research team, including engineers from the University of Cambridge and Zhejiang University, has developed a ...
Synthetic cannabinoids, a class of new psychoactive substances, have emerged as a significant public health and social stability threat due to their structural diversity, rapid iteration, and stronger ...
SPHEREx is scanning the entire sky in 102 infrared colors, beaming weekly data to a public archive so scientists and citizen ...
Explore how in-line Raman and NIR spectroscopy, combined with chemometrics, enables real-time reaction monitoring for better ...
The bending vibrational spectrum of the perdeutero isotopomer of the water trimer anion has been measured and compared with spectra calculated using the MP2, CCSD, and Becke3LYP electronic structure ...
Spectrum customers will get Hulu and previously axed Disney channels under new deal The deal between Charter and Disney will "expand Spectrum’s entertainment offering and create meaningful value ...
Reliable Modeling of Anharmonic Spectra Line-Shapes from VPT2 and Hybrid QM Models: IR Spectrum of Uracil as a Test Case ...
We investigated the correlation between the temperature coefficient of elasticity (TCE) and Fourier transform infrared (FT-IR) absorption spectra of SiO 2 for SAW devices. The measurement indicated ...
Abstract: High-performance vertically illuminated Schottky photodiodes with indium-tin-oxide (ITO) Schottky layers were designed, fabricated, and tested. Ternary and quarternary III-V material systems ...
A high-resolution scheme for converting two-dimensional infrared images to the visible region has exciting consequences for applications such as night-vision technology and chemical sensing.
Extra crews were brought in, and Spectrum said service had been restored to the Ventura area by 9 a.m. Some local residents, however, reported service interruptions throughout the day.
Key Takeaways Mitomycin for intravesical solution is the first FDA-approved treatment for recurrent LG-IR-NMIBC, with availability expected by July 2025. The phase 3 ENVISION trial demonstrated a 78% ...